跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OXYTROL oxybutynin 3.9 mg/day transdermal drug delivery system - TGA Drug Approval Details
Approvals
/
TGA
/
OXYTROL oxybutynin 3.9 mg/day transdermal drug delivery system
Approved
STANDARD
OXYTROL oxybutynin 3.9 mg/day transdermal drug delivery system
Theramex Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
0313a478379f10f5
Company
Theramex Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
0313a478379f10f5
Product Name
OXYTROL oxybutynin 3.9 mg/day transdermal drug delivery system
Artg Id
125489
Artg Name
OXYTROL oxybutynin 3.9 mg/day transdermal drug delivery system
Sponsor
Theramex Australia Pty Ltd
Company Detail Path
/organization/theramex-australia-pty-ltd
Artg Date
2007-05-10
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/5438e01495cf0fa3a9a736e57ff7fc85.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/edf516e0c1a74bbcc5daaea60250d412.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
0313a478379f10f5
Type
Standard
Back to TGA Approvals